Juvenescence US Corp. - Mar 14, 2023 Form 3 Insider Report for AgeX Therapeutics, Inc. (AGE)

Role
Director, 10%+ Owner
Signature
/s/ David Gill, Vice President and Treasurer
Stock symbol
AGE
Transactions as of
Mar 14, 2023
Transactions value $
$0
Form type
3
Date filed
3/22/2023, 04:19 PM
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AGE Common Stock 16.4M Mar 14, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired pursuant to a transfer of securities from the reporting person's sole stockholder, Juvenescence Limited.

Remarks:

Director by deputization